Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
When used as part of antidiabetic therapy, the dosage of this medication should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily dose of each component: empagliflozin 25mg and metformin hydrochloride extended-release 2000mg.
To reduce gastrointestinal adverse reactions caused by metformin, this medication should be taken once daily with a meal in the evening.
Take 1 tablet of this medication 10/1000 mg extended-release tablet or 25/1000 mg extended-release tablet once daily.
Patients taking this medication 5/1000 mg extended-release tablet, 12.5/1000 mg extended-release tablet, 5/750mg extended-release tablet, or 12.5/750mg extended-release tablet should take 2 tablets together once daily.
To reduce gastrointestinal adverse reactions associated with metformin use, the dose of metformin hydrochloride should be increased gradually.
To maintain the extended-release properties, swallow this medication whole without splitting, crushing, grinding, or chewing it.
For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medications such as insulin, the recommended initial total daily dose when taking this medication is empagliflozin 10 mg and their existing metformin dose. If empagliflozin 10 mg is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg.
Patients switching from combination therapy with empagliflozin and metformin to this medication should receive their existing doses of empagliflozin and metformin.
When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and dosage adjustments made as appropriate.
Because dosage adjustment based on renal function may be necessary, assessment of renal function is recommended before starting this medication and periodically during treatment.
No dosage adjustment of this medication is necessary in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60 mL/min or estimated glomerular filtration rate (eGFR) ≧60 mL/min/1.73 m2].
In patients with moderate renal impairment [CKD stage 3A, creatinine clearance (CrCl) ≧ 45 mL/min and <60mL/min or estimated glomerular filtration rate (eGFR) ≧ 45 mL/min/1.73m2 and <60mL/min/1.73m2], this medication may be used by adjusting the dose of metformin hydrochloride as follows, provided it is well tolerated and the patient has no other condition that may increase the risk of lactic acidosis.
- The starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily; therefore, treatment should not be initiated with this medication.
The maximum daily dose of metformin hydrochloride is 1000mg.
If creatinine clearance (CrCl) decreases to below 45 ml/min or estimated glomerular filtration rate (eGFR) decreases to below 45 ml/min/1.73m2, this medication must be discontinued immediately.
In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
Improvement of glycemic control in adults with type 2 diabetes mellitus
Abnormal glucose control
type 2 diabetes
cardiovascular disease
View approved original textHide original text
This medication is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes who are treated with both empagliflozin and metformin. Patients with existing cardiovascular disease who have insufficient glycemic control should consult a specialist for clinical trial information. This medication effectively aids in glycemic management and contributes to the treatment of diabetes.
How to take
Adult dose
When used as part of antidiabetic therapy, the dosage of this medication should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily dose of each component: empagliflozin 25mg and metformin hydrochloride extended-release 2000mg.
To reduce gastrointestinal adverse reactions caused by metformin, this medication should be taken once daily with a meal in the evening.
Take 1 tablet of this medication 10/1000 mg extended-release tablet or 25/1000 mg extended-release tablet once daily.
Patients taking this medication 5/1000 mg extended-release tablet, 12.5/1000 mg extended-release tablet, 5/750mg extended-release tablet, or 12.5/750mg extended-release tablet should take 2 tablets together once daily.
To reduce gastrointestinal adverse reactions associated with metformin use, the dose of metformin hydrochloride should be increased gradually.
To maintain the extended-release properties, swallow this medication whole without splitting, crushing, grinding, or chewing it.
For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medications such as insulin, the recommended initial total daily dose when taking this medication is empagliflozin 10 mg and their existing metformin dose. If empagliflozin 10 mg is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg.
Patients switching from combination therapy with empagliflozin and metformin to this medication should receive their existing doses of empagliflozin and metformin.
When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and dosage adjustments made as appropriate.
Because dosage adjustment based on renal function may be necessary, assessment of renal function is recommended before starting this medication and periodically during treatment.
No dosage adjustment of this medication is necessary in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60 mL/min or estimated glomerular filtration rate (eGFR) ≧60 mL/min/1.73 m2].
In patients with moderate renal impairment [CKD stage 3A, creatinine clearance (CrCl) ≧ 45 mL/min and <60mL/min or estimated glomerular filtration rate (eGFR) ≧ 45 mL/min/1.73m2 and <60mL/min/1.73m2], this medication may be used by adjusting the dose of metformin hydrochloride as follows, provided it is well tolerated and the patient has no other condition that may increase the risk of lactic acidosis.
- The starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily; therefore, treatment should not be initiated with this medication.
The maximum daily dose of metformin hydrochloride is 1000mg.
If creatinine clearance (CrCl) decreases to below 45 ml/min or estimated glomerular filtration rate (eGFR) decreases to below 45 ml/min/1.73m2, this medication must be discontinued immediately.
In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
Precautions
This medication is used for the treatment of diabetes and should not be administered to patients with impaired renal function or severe liver disease.
This medication can cause a rare but very serious side effect known as lactic acidosis; therefore, if the patient is in a state of dehydration, severe infection, or decreased heart function, administration should be discontinued.
During the course of treatment, hypoglycemic symptoms may occur, so caution is particularly needed when used in conjunction with insulin or other antidiabetic agents.
Urinary tract infections or genital infections may occur, so if symptoms of infection develop, consultation with healthcare providers should occur immediately.
This medication can cause a decrease in fluid volume, so caution should be exercised regarding blood pressure and fluid status in patients at high risk of dehydration or the elderly.
Pregnant or breastfeeding women are advised not to use this medication, especially during pregnancy where insulin therapy is recommended.
If surgery is planned or if examinations using iodine contrast media are to be performed, administration of this medication should be discontinued for a certain period before and after the examination.
This medication must be swallowed whole and should not be chewed or crushed.
Vitamin B12 deficiency may occur, so it is necessary to monitor blood levels of vitamin B12 regularly during prolonged use.
In case of overdose, severe side effects such as lactic acidosis could occur, so dosage must be strictly followed, and any unusual symptoms should be reported to a healthcare provider immediately.
It is advisable to avoid alcohol consumption during treatment, as well as irregular meals or excessive exercise.
Elderly patients may have decreased renal function, necessitating regular kidney function tests, while ensuring they do not exceed the maximum dosage.
This medication may interact with other drugs, so it is essential to inform healthcare providers about any other medications being taken.
Caution is required during activities such as driving or operating machinery while taking this medication.
Side effects
hypoglycemia
urinary tract infection
genital infection
increased urination
decreased vitamin B12 and deficiency
ketoacidosis
lactic acidosis
decreased fluid volume
nausea
vomiting
Show 164 moreCollapse
diarrhea
abdominal pain
loss of appetite
constipation
abnormal liver function tests
hepatitis
taste disturbance
itching
rash
hives
erythema
angioedema
dysuria
interstitial nephritis
thirst
increased serum lipids
increased serum creatinine
decreased glomerular filtration rate
increased hematocrit
perineal necrosis
chronic gastritis
various neurological disorders
cerebral infarction
soft tissue infection
pneumonia
ankle fracture
epicondylitis
facial bone fracture
musculoskeletal pain
myocardial infarction
ketoacidosis
urosepsis
pyelonephritis
rash
hives
angioedema
perineal necrosis
diarrhea
nausea
gastric ulcer
colitis
vomiting
ischemic colitis
gastrointestinal bleeding
headache
dizziness
insomnia
anxiety
hyperglycemia
hyponatremia
weight loss
vulvar pruritus
genital pruritus
glaucoma
diabetic retinopathy
cough
dyspnea
angina pectoris
hypertension
tachycardia
arteriosclerosis
deep vein thrombosis
diabetic vascular disorders
peripheral artery occlusive disease
unstable angina
dysmenorrhea
positional vertigo
vertigo
anemia
lymphadenopathy
hypothyroidism
thyroid nodule
acute cholecystitis
autoimmune hepatitis
cholelithiasis
hepatitis
dysmenorrhea
positional vertigo
hematuria
urinary stones
ureteral calculi
acute kidney injury
chronic kidney disease
hematuria
overactive bladder
renal mass
urinary retention
urinary pain
urinary abnormalities
cervicitis
benign prostatic hyperplasia
erectile dysfunction
atrophic vaginitis
cervical dysplasia
cervicitis
scrotal pain
sexual dysfunction
vaginal discharge
hypoglycemia
decreased appetite
obesity
sequelae
diabetes mellitus
hyperlipidemia
dyslipidemia
dermoid cyst
seborrheic dermatitis
atopic dermatitis
diabetic foot
nummular eczema
heat rash
sebaceous gland hyperplasia
lumbar spinal canal stenosis
myalgia
limb pain
musculoskeletal chest pain
arthralgia
cervical stenosis
fibromyalgia
flank pain
fracture pain
muscle weakness
osteoarthritis
osteoporosis
rotator cuff syndrome
astigmatism
cataract
allergic conjunctivitis
blurred vision
corneal erosion
macular fibrosis
ocular discomfort
conjunctival hyperemia
pathological myopia
retinal detachment
retinal crystals
retinal vein occlusion
exudative retinal detachment
eyelid swelling
visual impairment
vitreous floaters
vitreous hemorrhage
epistaxis
asthma
exertional dyspnea
wet cough
allergic rhinitis
residual sputum
skin lacerations
rib fractures
iliotibial band syndrome
limb injuries
bruising
concussion
corneal abrasion
falls
hand fractures
iliotibial band syndrome
open globe injury
pelvic fractures
road traffic accidents
splenic injury
sternum fracture
palpitations
Not everyone experiences these, and they can vary from person to person.
Storage
This medication may be sensitive to air and moisture; therefore, it should be stored in a closed container. The storage temperature should ideally be maintained between 1 to 30 degrees Celsius at room temperature.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.